S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR).

Linnea M. Baudhuin, Ying Jiang, Alexander Zaslavsky, Isao Ishii, Jerold Chun, Yan Xu

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Akt plays a pivotal role in cell survival and tumorigenesis. We investigated the potential interaction between sphingosine-1-phosphate (S1P) and platelet-derived growth factor (PDGF) in the Akt signaling pathway. Using mouse embryonic fibroblasts (MEFs) from S1P receptor knockout mice, we show here that S1P3 was required for S473 phosphorylation of Akt by S1P. In addition, S1P-stimulated activation of Akt, but not ERK, was blocked by a PDGF receptor (PDGFR)-specific inhibitor, AG1296, suggesting a S1P3-mediated specific crosstalk between the Akt signaling pathways of S1P and PDGFR in MEFs. We investigated this crosstalk under different conditions and found that both Akt and ERK activation induced by S1P, but not lysophosphatidic acid (LPA), in HEY ovarian cancer cells required PDGFR but not epidermal growth factor receptor (EGFR) or insulin-like growth factor-I receptor (IGFR). Importantly, S1P induced a Gi-dependent tyrosine phosphorylation of PDGFR in HEY cells. This dependence on PDGFR in S1P-induced Akt activation was also observed in A2780, T47D, and HMEC-1 cells (which express S1P3), but not in PC-3 or GI-101A cells (which do not express S1P3), further supporting that S1P3 mediates the crosstalk between S1P and PDGFR. This is the first report demonstrating a unique interaction between S1P3 and PDGFR, in addition to demonstrating a specific role for S1P3 in S1P-induced Akt activation.

Original languageEnglish
Pages (from-to)341-343
Number of pages3
JournalThe FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Volume18
Issue number2
Publication statusPublished - 2004
Externally publishedYes

Fingerprint

Platelet-Derived Growth Factor Receptors
Chemical activation
Crosstalk
Phosphorylation
Fibroblasts
Cells
Lysosphingolipid Receptors
sphingosine 1-phosphate
IGF Type 1 Receptor
Platelet-Derived Growth Factor
Epidermal Growth Factor Receptor
Knockout Mice
Ovarian Neoplasms
Tyrosine
Cell Survival
Carcinogenesis

Cite this

S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR). / Baudhuin, Linnea M.; Jiang, Ying; Zaslavsky, Alexander; Ishii, Isao; Chun, Jerold; Xu, Yan.

In: The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 18, No. 2, 2004, p. 341-343.

Research output: Contribution to journalArticle

Baudhuin, Linnea M. ; Jiang, Ying ; Zaslavsky, Alexander ; Ishii, Isao ; Chun, Jerold ; Xu, Yan. / S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR). In: The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2004 ; Vol. 18, No. 2. pp. 341-343.
@article{374b939efe89473f8d6d04d859514d45,
title = "S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR).",
abstract = "Akt plays a pivotal role in cell survival and tumorigenesis. We investigated the potential interaction between sphingosine-1-phosphate (S1P) and platelet-derived growth factor (PDGF) in the Akt signaling pathway. Using mouse embryonic fibroblasts (MEFs) from S1P receptor knockout mice, we show here that S1P3 was required for S473 phosphorylation of Akt by S1P. In addition, S1P-stimulated activation of Akt, but not ERK, was blocked by a PDGF receptor (PDGFR)-specific inhibitor, AG1296, suggesting a S1P3-mediated specific crosstalk between the Akt signaling pathways of S1P and PDGFR in MEFs. We investigated this crosstalk under different conditions and found that both Akt and ERK activation induced by S1P, but not lysophosphatidic acid (LPA), in HEY ovarian cancer cells required PDGFR but not epidermal growth factor receptor (EGFR) or insulin-like growth factor-I receptor (IGFR). Importantly, S1P induced a Gi-dependent tyrosine phosphorylation of PDGFR in HEY cells. This dependence on PDGFR in S1P-induced Akt activation was also observed in A2780, T47D, and HMEC-1 cells (which express S1P3), but not in PC-3 or GI-101A cells (which do not express S1P3), further supporting that S1P3 mediates the crosstalk between S1P and PDGFR. This is the first report demonstrating a unique interaction between S1P3 and PDGFR, in addition to demonstrating a specific role for S1P3 in S1P-induced Akt activation.",
author = "Baudhuin, {Linnea M.} and Ying Jiang and Alexander Zaslavsky and Isao Ishii and Jerold Chun and Yan Xu",
year = "2004",
language = "English",
volume = "18",
pages = "341--343",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "2",

}

TY - JOUR

T1 - S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR).

AU - Baudhuin, Linnea M.

AU - Jiang, Ying

AU - Zaslavsky, Alexander

AU - Ishii, Isao

AU - Chun, Jerold

AU - Xu, Yan

PY - 2004

Y1 - 2004

N2 - Akt plays a pivotal role in cell survival and tumorigenesis. We investigated the potential interaction between sphingosine-1-phosphate (S1P) and platelet-derived growth factor (PDGF) in the Akt signaling pathway. Using mouse embryonic fibroblasts (MEFs) from S1P receptor knockout mice, we show here that S1P3 was required for S473 phosphorylation of Akt by S1P. In addition, S1P-stimulated activation of Akt, but not ERK, was blocked by a PDGF receptor (PDGFR)-specific inhibitor, AG1296, suggesting a S1P3-mediated specific crosstalk between the Akt signaling pathways of S1P and PDGFR in MEFs. We investigated this crosstalk under different conditions and found that both Akt and ERK activation induced by S1P, but not lysophosphatidic acid (LPA), in HEY ovarian cancer cells required PDGFR but not epidermal growth factor receptor (EGFR) or insulin-like growth factor-I receptor (IGFR). Importantly, S1P induced a Gi-dependent tyrosine phosphorylation of PDGFR in HEY cells. This dependence on PDGFR in S1P-induced Akt activation was also observed in A2780, T47D, and HMEC-1 cells (which express S1P3), but not in PC-3 or GI-101A cells (which do not express S1P3), further supporting that S1P3 mediates the crosstalk between S1P and PDGFR. This is the first report demonstrating a unique interaction between S1P3 and PDGFR, in addition to demonstrating a specific role for S1P3 in S1P-induced Akt activation.

AB - Akt plays a pivotal role in cell survival and tumorigenesis. We investigated the potential interaction between sphingosine-1-phosphate (S1P) and platelet-derived growth factor (PDGF) in the Akt signaling pathway. Using mouse embryonic fibroblasts (MEFs) from S1P receptor knockout mice, we show here that S1P3 was required for S473 phosphorylation of Akt by S1P. In addition, S1P-stimulated activation of Akt, but not ERK, was blocked by a PDGF receptor (PDGFR)-specific inhibitor, AG1296, suggesting a S1P3-mediated specific crosstalk between the Akt signaling pathways of S1P and PDGFR in MEFs. We investigated this crosstalk under different conditions and found that both Akt and ERK activation induced by S1P, but not lysophosphatidic acid (LPA), in HEY ovarian cancer cells required PDGFR but not epidermal growth factor receptor (EGFR) or insulin-like growth factor-I receptor (IGFR). Importantly, S1P induced a Gi-dependent tyrosine phosphorylation of PDGFR in HEY cells. This dependence on PDGFR in S1P-induced Akt activation was also observed in A2780, T47D, and HMEC-1 cells (which express S1P3), but not in PC-3 or GI-101A cells (which do not express S1P3), further supporting that S1P3 mediates the crosstalk between S1P and PDGFR. This is the first report demonstrating a unique interaction between S1P3 and PDGFR, in addition to demonstrating a specific role for S1P3 in S1P-induced Akt activation.

UR - http://www.scopus.com/inward/record.url?scp=1442265704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1442265704&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 341

EP - 343

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 2

ER -